CoChat
Sign Up
Cited by 849

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Function of miR-146a in Controlling Treg Cell-Mediated Regulation of Th1 Responses

Lu, Li-Fan, Boldin, Mark P., Chaudhry, Ashutosh, Lin, Ling-Li, Taganov, Konstantin D., Hanada, Toshikatsu, Yoshimura, Akihiko, Baltimore, David, Rudensky, Alexander Y.·2010·Cell
DOI 10.1016/j.cell.2010.08.012PMC PMC3049116
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.cell.2010.08.012

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 49

  1. Alexander, 1999, SOCS1 is a critical inhibitor of interferon gamma signaling and prevents the potentially fatal neonatal actions of this cytokine, Cell, 98, 597, 10.1016/S0092-8674(00)80047-1 · DOI · Paper page
  2. Barbi, 2007, IFN-gamma and STAT1 are required for efficient induction of CXC chemokine receptor 3 (CXCR3) on CD4+ but not CD8+ T cells, Blood, 110, 2215, 10.1182/blood-2007-03-081307 · DOI
  3. Beima, 2006, T-bet binding to newly identified target gene promoters is cell type-independent but results in variable context-dependent functional effects, J. Biol. Chem., 281, 11992, 10.1074/jbc.M513613200 · DOI
  4. Belkaid, 2009, Regulatory T cells in the control of host-microorganism interactions (∗), Annu. Rev. Immunol., 27, 551, 10.1146/annurev.immunol.021908.132723 · DOI
  5. Ben-Sasson, 2009, IL-1 acts directly on CD4 T cells to enhance their antigen-driven expansion and differentiation, Proc. Natl. Acad. Sci. USA, 106, 7119, 10.1073/pnas.0902745106 · DOI · Paper page
  6. Cameron, 2008, Epstein-Barr virus latent membrane protein 1 induces cellular MicroRNA miR-146a, a modulator of lymphocyte signaling pathways, J. Virol., 82, 1946, 10.1128/JVI.02136-07 · DOI
  7. Chen, 2005, Real-time quantification of microRNAs by stem-loop RT-PCR, Nucleic Acids Res., 33, e179, 10.1093/nar/gni178 · DOI
  8. Chong, 2008, The RNAseIII enzyme Drosha is critical in T cells for preventing lethal inflammatory disease, J. Exp. Med., 205, 2005, 10.1084/jem.20081219 · DOI
  9. Chung, 2009, Critical regulation of early Th17 cell differentiation by interleukin-1 signaling, Immunity, 30, 576, 10.1016/j.immuni.2009.02.007 · DOI
  10. Cobb, 2006, A role for Dicer in immune regulation, J. Exp. Med., 203, 2519, 10.1084/jem.20061692 · DOI
  11. Curtale, 2010, An emerging player in the adaptive immune response: microRNA-146a is a modulator of IL-2 expression and activation-induced cell death in T lymphocytes, Blood, 115, 265, 10.1182/blood-2009-06-225987 · DOI · Paper page
  12. Fontenot, 2003, Foxp3 programs the development and function of CD4+CD25+ regulatory T cells, Nat. Immunol., 4, 330, 10.1038/ni904 · DOI · Paper page
  13. Fontenot, 2005, Regulatory T cell lineage specification by the forkhead transcription factor foxp3, Immunity, 22, 329, 10.1016/j.immuni.2005.01.016 · DOI
  14. Gavin, 2007, Foxp3-dependent programme of regulatory T-cell differentiation, Nature, 445, 771, 10.1038/nature05543 · DOI
  15. Horino, 2008, Suppressor of cytokine signaling-1 ameliorates dextran sulfate sodium-induced colitis in mice, Int. Immunol., 20, 753, 10.1093/intimm/dxn033 · DOI
  16. Hou, 2009, MicroRNA-146a feedback inhibits RIG-I-dependent Type I IFN production in macrophages by targeting TRAF6, IRAK1, and IRAK2, J. Immunol., 183, 2150, 10.4049/jimmunol.0900707 · DOI · Paper page
  17. Hsieh, 2006, An intersection between the self-reactive regulatory and nonregulatory T cell receptor repertoires, Nat. Immunol., 7, 401, 10.1038/ni1318 · DOI
  18. Hu, 2009, Cross-regulation of signaling pathways by interferon-gamma: implications for immune responses and autoimmune diseases, Immunity, 31, 539, 10.1016/j.immuni.2009.09.002 · DOI · Paper page
  19. Huang, 2009, miR-142-3p restricts cAMP production in CD4+CD25- T cells and CD4+CD25+ TREG cells by targeting AC9 mRNA, EMBO Rep., 10, 180, 10.1038/embor.2008.224 · DOI
  20. Jazdzewski, 2008, Common SNP in pre-miR-146a decreases mature miR expression and predisposes to papillary thyroid carcinoma, Proc. Natl. Acad. Sci. USA, 105, 7269, 10.1073/pnas.0802682105 · DOI · Paper page
  21. Khattri, 2003, An essential role for Scurfin in CD4+CD25+ T regulatory cells, Nat. Immunol., 4, 337, 10.1038/ni909 · DOI
  22. Kim, 2007, Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice, Nat. Immunol., 8, 191, 10.1038/ni1428 · DOI
  23. Koch, 2009, The transcription factor T-bet controls regulatory T cell homeostasis and function during type 1 inflammation, Nat. Immunol., 10, 595, 10.1038/ni.1731 · DOI · Paper page
  24. Kohlhaas, 2009, Cutting edge: the Foxp3 target miR-155 contributes to the development of regulatory T cells, J. Immunol., 182, 2578, 10.4049/jimmunol.0803162 · DOI
  25. Kubo, 2003, Suppressors of cytokine signaling and immunity, Nat. Immunol., 4, 1169, 10.1038/ni1012 · DOI
  26. Lal, 2009, miR-24 Inhibits cell proliferation by targeting E2F2, MYC, and other cell-cycle genes via binding to “seedless” 3′UTR microRNA recognition elements, Mol. Cell, 35, 610, 10.1016/j.molcel.2009.08.020 · DOI
  27. Lin, 2007, Regulatory T cell development in the absence of functional Foxp3, Nat. Immunol., 8, 359, 10.1038/ni1445 · DOI
  28. Liston, 2008, Dicer-dependent microRNA pathway safeguards regulatory T cell function, J. Exp. Med., 205, 1993, 10.1084/jem.20081062 · DOI
  29. Lord, 2005, T-bet is required for optimal proinflammatory CD4+ T-cell trafficking, Blood, 106, 3432, 10.1182/blood-2005-04-1393 · DOI · Paper page
  30. Lu, 2009, Molecular orchestration of differentiation and function of regulatory T cells, Genes Dev., 23, 1270, 10.1101/gad.1791009 · DOI
  31. Lu, 2009, Foxp3-dependent microRNA155 confers competitive fitness to regulatory T cells by targeting SOCS1 protein, Immunity, 30, 80, 10.1016/j.immuni.2008.11.010 · DOI
  32. Maitra, 2009, Differential regulation of Foxp3 and IL-17 expression in CD4 T helper cells by IRAK-1, J. Immunol., 182, 5763, 10.4049/jimmunol.0900124 · DOI
  33. Marine, 1999, SOCS1 deficiency causes a lymphocyte-dependent perinatal lethality, Cell, 98, 609, 10.1016/S0092-8674(00)80048-3 · DOI
  34. Marson, 2007, Foxp3 occupancy and regulation of key target genes during T-cell stimulation, Nature, 445, 931, 10.1038/nature05478 · DOI · Paper page
  35. Meraz, 1996, Targeted disruption of the Stat1 gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway, Cell, 84, 431, 10.1016/S0092-8674(00)81288-X · DOI · Paper page
  36. Monticelli, 2005, MicroRNA profiling of the murine hematopoietic system, Genome Biol., 6, R71, 10.1186/gb-2005-6-8-r71 · DOI · Paper page
  37. Nakajima, 2002, Induction of the chemokine receptor CXCR3 on TCR-stimulated T cells: dependence on the release from persistent TCR-triggering and requirement for IFN-gamma stimulation, Eur. J. Immunol., 32, 1792, 10.1002/1521-4141(200206)32:6<1792::AID-IMMU1792>3.0.CO;2-0 · DOI
  38. O'Connell, 2007, MicroRNA-155 is induced during the macrophage inflammatory response, Proc. Natl. Acad. Sci. USA, 104, 1604, 10.1073/pnas.0610731104 · DOI · Paper page
  39. Oldenhove, 2009, Decrease of Foxp3+ Treg cell number and acquisition of effector cell phenotype during lethal infection, Immunity, 31, 772, 10.1016/j.immuni.2009.10.001 · DOI
  40. Schmitz, 2005, IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines, Immunity, 23, 479, 10.1016/j.immuni.2005.09.015 · DOI
  41. Siebler, 2003, A key pathogenic role for the STAT1/T-bet signaling pathway in T-cell-mediated liver inflammation, Hepatology, 38, 1573
  42. Tanaka, 2008, Loss of suppressor of cytokine signaling 1 in helper T cells leads to defective Th17 differentiation by enhancing antagonistic effects of IFN-gamma on STAT3 and Smads, J. Immunol., 180, 3746, 10.4049/jimmunol.180.6.3746 · DOI
  43. Tang, 2009, MicroRNA-146A contributes to abnormal activation of the type I interferon pathway in human lupus by targeting the key signaling proteins, Arthritis Rheum., 60, 1065, 10.1002/art.24436 · DOI
  44. Thai, 2007, Regulation of the germinal center response by microRNA-155, Science, 316, 604, 10.1126/science.1141229 · DOI
  45. Williams, 2007, Maintenance of the Foxp3-dependent developmental program in mature regulatory T cells requires continued expression of Foxp3, Nat. Immunol., 8, 277, 10.1038/ni1437 · DOI
  46. Zhan, 2009, SOCS1 negatively regulates the production of Foxp3+ CD4+ T cells in the thymus, Immunol. Cell Biol., 87, 473, 10.1038/icb.2009.23 · DOI
  47. Zheng, 2009, Regulatory T-cell suppressor program co-opts transcription factor IRF4 to control T(H)2 responses, Nature, 458, 351, 10.1038/nature07674 · DOI · Paper page
  48. Zhou, 2008, Selective miRNA disruption in T reg cells leads to uncontrolled autoimmunity, J. Exp. Med., 205, 1983, 10.1084/jem.20080707 · DOI
  49. Zhou, 2009, Instability of the transcription factor Foxp3 leads to the generation of pathogenic memory T cells in vivo, Nat. Immunol., 10, 1000, 10.1038/ni.1774 · DOI

Cited by

Sorted by citations

Metadata

Authors
Lu, L.-F., Boldin, M. P., Chaudhry, A., Lin, L.-L., Taganov, K. D., Hanada, T., Yoshimura, A., Baltimore, D., & Rudensky, A. Y.
Venue
Cell
Publisher
Elsevier BV
Published
2010-09
Volume
142
Issue
6
Pages
914-929
ISSN
0092-8674
DOI
10.1016/j.cell.2010.08.012
PMC
PMC3049116
Cited by
849
References
7
Language
en
Licence
Funders
  • National Institute of Biomedical Innovation
  • National Institutes of Health
  • Ministry of Education, Culture, Sports, Science and Technology

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review